News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
176,173 Results
Type
Article (7228)
Company Profile (64)
Press Release (168880)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (53676)
Career Advice (211)
Deals (9065)
Drug Delivery (9)
Drug Development (24617)
Employer Resources (22)
FDA (4224)
Job Trends (4192)
News (89508)
Policy (7313)
Tag
Academia (500)
Accelerated approval (7)
Adcomms (2)
Allergies (57)
Alliances (7580)
ALS (73)
Alzheimer's disease (645)
Antibody-drug conjugate (ADC) (118)
Approvals (4505)
Artificial intelligence (203)
Autoimmune disease (58)
Automation (17)
Bankruptcy (48)
Best Places to Work (3962)
BIOSECURE Act (4)
Biosimilars (74)
Biotechnology (33)
Bladder cancer (106)
Brain cancer (23)
Breast cancer (331)
Cancer (2223)
Cardiovascular disease (179)
Career advice (191)
Career pathing (10)
CAR-T (85)
CDC (6)
Cell therapy (234)
Cervical cancer (20)
Clinical research (23093)
Collaboration (641)
Company closure (2)
Compensation (431)
Complete response letters (12)
COVID-19 (939)
CRISPR (33)
C-suite (265)
Cystic fibrosis (60)
Data (3097)
Depression (37)
Diabetes (189)
Diagnostics (1895)
Digital health (21)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (82)
Drug pricing (21)
Drug shortages (4)
Duchenne muscular dystrophy (97)
Earnings (41204)
Editorial (9)
Employer branding (2)
Employer resources (22)
Events (28574)
Executive appointments (405)
FDA (5673)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (8)
Funding (570)
Gene editing (68)
Generative AI (11)
Gene therapy (195)
GLP-1 (330)
Government (1297)
Grass and pollen (3)
Guidances (325)
Healthcare (5712)
HIV (34)
Huntington's disease (21)
IgA nephropathy (44)
Immunology and inflammation (71)
Immuno-oncology (8)
Indications (39)
Infectious disease (1047)
Inflammatory bowel disease (57)
Inflation Reduction Act (1)
Influenza (42)
Intellectual property (64)
Interviews (40)
IPO (5760)
IRA (3)
Job creations (536)
Job search strategy (151)
Kidney cancer (8)
Labor market (22)
Layoffs (103)
Leadership (4)
Legal (1193)
Liver cancer (34)
Longevity (5)
Lung cancer (333)
Lymphoma (209)
Machine learning (16)
Management (7)
Manufacturing (235)
MASH (96)
Medical device (3931)
Medtech (3944)
Mergers & acquisitions (3761)
Metabolic disorders (478)
Multiple sclerosis (83)
NASH (10)
Neurodegenerative disease (118)
Neuropsychiatric disorders (21)
Neuroscience (1098)
NextGen: Class of 2025 (1263)
Non-profit (1060)
Now hiring (3)
Obesity (189)
Opinion (21)
Ovarian cancer (63)
Pain (60)
Pancreatic cancer (83)
Parkinson's disease (102)
Partnered (6)
Patents (125)
Patient recruitment (163)
Peanut (26)
People (8256)
Pharmaceutical (15)
Pharmacy benefit managers (5)
Phase I (6031)
Phase II (9812)
Phase III (9109)
Pipeline (2449)
Policy (20)
Postmarket research (862)
Preclinical (1949)
Press Release (16)
Prostate cancer (123)
Psychedelics (4)
Radiopharmaceuticals (67)
Rare diseases (258)
Real estate (888)
Recruiting (13)
Regulatory (6282)
Reports (18)
Research institute (516)
Resumes & cover letters (18)
Rett syndrome (16)
RNA editing (2)
RSV (42)
Schizophrenia (51)
Series A (84)
Series B (66)
Sickle cell disease (39)
Special edition (11)
Spinal muscular atrophy (60)
Sponsored (8)
Startups (481)
Stomach cancer (2)
Supply chain (38)
Tariffs (12)
The Weekly (3)
Vaccines (349)
Venture capital (18)
Weight loss (122)
Women's health (31)
Worklife (5)
Date
Today (32)
Last 7 days (231)
Last 30 days (1087)
Last 365 days (15002)
2025 (14845)
2024 (12052)
2023 (10779)
2022 (22611)
2021 (20163)
2020 (12692)
2019 (10292)
2018 (7758)
2017 (7126)
2016 (5759)
2015 (7551)
2014 (5326)
2013 (3782)
2012 (4524)
2011 (4663)
2010 (4260)
Location
Africa (132)
Alabama (20)
Alaska (2)
Arizona (58)
Arkansas (4)
Asia (10501)
Australia (1426)
California (5011)
Canada (1234)
China (378)
Colorado (201)
Connecticut (281)
Delaware (209)
Europe (24614)
Florida (532)
Georgia (133)
Hawaii (3)
Idaho (14)
Illinois (386)
India (21)
Indiana (220)
Iowa (9)
Japan (248)
Kansas (22)
Kentucky (11)
Louisiana (12)
Maine (30)
Maryland (601)
Massachusetts (3663)
Michigan (97)
Minnesota (295)
Mississippi (2)
Missouri (56)
Montana (7)
Nebraska (3)
Nevada (59)
New Hampshire (22)
New Jersey (1465)
New Mexico (6)
New York (1241)
North Carolina (492)
North Dakota (1)
Northern California (2403)
Ohio (113)
Oklahoma (5)
Oregon (14)
Pennsylvania (825)
Puerto Rico (8)
Rhode Island (14)
South America (187)
South Carolina (10)
Southern California (1905)
Tennessee (72)
Texas (733)
United States (17146)
Utah (101)
Virginia (126)
Washington D.C. (27)
Washington State (419)
West Virginia (2)
Wisconsin (80)
Wyoming (1)
176,173 Results for "24".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anti-hypertensive Drugs Market Size to Hit USD 37.24 Billion by 2034
November 17, 2025
·
1 min read
Press Releases
Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft
December 18, 2025
·
7 min read
Press Releases
Antifungal Drugs Market Size to Worth USD 24.25 Billion by 2034
November 5, 2025
·
1 min read
Press Releases
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - November 24, 2025
November 25, 2025
·
1 min read
Press Releases
Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial
November 10, 2025
·
15 min read
Press Releases
Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24
October 31, 2025
·
1 min read
Press Releases
U.S. Single-use Bioprocessing Market Size to Hit USD 39.24 Billion by 2034
November 4, 2025
·
1 min read
Press Releases
Kneat to Present at The Emerging Growth Conference on September 24, 2025
Kneat invites investors to real-time, interactive engagement with CEO Eddie Ryan
September 17, 2025
·
1 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 24, 2025
October 27, 2025
·
1 min read
Press Releases
Agilent Announces Cash Dividend of 24.8 Cents per Share
September 18, 2025
·
1 min read
1 of 17,618
Next
